Public Company News

Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer

Highlights * United States Food and Drug Administration (U.S. FDA) provided positive feedback on a pivotal Phase III trial for64Cu-SAR-bisPSMA diagnostic in prostate cancer patients with biochemical recurrence (BCR), AMPLIFY. * The positive results of the completed COBRA and PROPELLER trials,...

2024-10-14 21:02 1744

Hyundai Mobis Partners with ZEISS: The Entire Windshield Becomes a Full-Display Screen

* Business cooperation agreement signed with German optical company ZEISS for the development of 'Holographic Windshield Display' technology for vehicles * Utilizes the windshield as a large monitor to display driving information, navigation, and convenience features * Emphasize differenti...

2024-10-14 20:00 1410

Global Sae-A Group Completes Construction of 36,000-Spindle Third Spinning Mill in Costa Rica

CARTAGO, Costa Rica, Oct. 14, 2024 /PRNewswire/ -- Global Sae-A Group, the holding company of Sae-A Trading, one of the world's largest apparel manufacturer, held an opening ceremony for its third spinning mill in Costa Rica on the 11th. From left ...

2024-10-14 20:00 929

TOYO Co., Ltd Announces Plans for a 2 GW Solar Cell Manufacturing Facility in Ethiopia

TOKYO, Oct. 14, 2024 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) ("TOYO" or the "Company"), a solar solution company, is excited to announce its plan to establish a state-of-the-art solar cell manufacturing facility with an expected annual capacity of 2 gigawatts (G...

2024-10-14 20:00 2716

Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development

* S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation * The platform can address challenges associated with viscosity and achieve stable liquid formulation for over 200 mg/mL subcutaneous administration INCHEON, South Korea, Oct. 14, 2024 /PRNe...

2024-10-14 19:00 1551

SurplusGLOBAL Accelerates Innovation in Semiconductor Equipment and Parts Ecosystem with AI... Appoints Dr. Benjamin Jeong as Chief AI Officer

SEOUL, South Korea, Oct. 14, 2024 /PRNewswire/ -- SurplusGLOBAL, a platform company specializing in semiconductor equipment and parts, is accelerating innovation in the semiconductor distribution industry by incorporating artificial intelligence (AI) technology. Aiming to expand its AI-driven bu...

2024-10-14 19:00 1624

US FDA issues Study May Proceed letter for the Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors, Sponsored by the US National Cancer Institute

TAIPEI and SAN DIEGO, Oct. 14, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that FDA issues Study May Proceed letter for its developing drug Pid...

2024-10-14 19:00 1630

Tencent Music Entertainment Group to Report Third Quarter 2024 Financial Results on November 12, 2024

SHENZHEN, China, Oct. 14, 2024 /PRNewswire/ -- Tencent Music Entertainment Group ("TME", or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, today announced that it will report its unaudited financial results for the third quarter of 2...

2024-10-14 18:00 2634

Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting

NEW YORK, Oct. 14, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading developer and provider of microwave ablation ("MWA") medical devices inChina, which recently expanded into the U.S. market following its U.S. FDA 510(k) clea...

2024-10-14 17:00 917

Zhejiang Taimei Medical Technology Co., Ltd. Is Now Listed on HKEX

HONG KONG, Oct. 13, 2024 /PRNewswire/ -- Zhejiang Taimei Medical Technology Co., Ltd. (the "Company"; Stock code: 2576.HK) has announced that the shares have started to be traded on the Main Board of the Stock Exchange of Hong Kong Limited under the stock code "2576" since today. The Company sai...

2024-10-14 10:18 1194

SEMIFIVE Extends Partnership with Arm to Advance AI and HPC SoC Platforms

Strengthening SoC platforms for high-performance custom silicon with Arm Neoverse CSS technology SEOUL, South Korea, Oct. 13, 2024 /PRNewswire/ -- SEMIFIVE, a leading design solution provider and pioneer in platform-based custom silicon, today announced the expansion of its collaboration with Ar...

2024-10-14 06:00 1258

Akeso Secures $250 Million USD to Propel Global Expansion of Its Innovative Drug Pipeline

Expediting International Clinical Trials for Pivotal Products Key Participants Include International Long-Term and Healthcare Funds HONG KONG, Oct. 13, 2024 /PRNewswire/ -- Akeso Biopharma (9926. HK) ("Akeso", the "Company" ) announced that it has successfully raised approximately$250 million US...

2024-10-13 20:27 3355

Sunvozertinib Granted Breakthrough Therapy Designation by China CDE for the First-Line Treatment of Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Fourth Breakthrough Therapy Designation for sunvozertinib in NSCLC with EGFR exon20ins SHANGHAI, Oct. 13, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the Center...

2024-10-13 16:04 2035

Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform

CAMBRIDGE, Mass., Oct. 12, 2024 /PRNewswire/ -- XtalPi, a global leader in AI drug discovery, announced today a license agreement between Ailux Biologics, a division of XtalPi Inc., and Janssen Biotech, Inc.,(Janssen) a Johnson & Johnson company, on one of its proprietary biologics AI platforms. ...

2024-10-12 16:57 4022

X3 Holdings Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price Requirement

SINGAPORE, Oct. 11, 2024 /PRNewswire/ -- X3 Holdings Co., Ltd. (Nasdaq: XTKG) (the "Company" or "XTKG"), a global provider of digital solutions and technology services spanning diverse industries, today announced that it has received an extension of 180 calendar days from the Listing Qualificatio...

2024-10-12 04:30 5292

China Liberal Education Holdings Limited Reports Financial Results for the First Six Months of Fiscal Year 2024

BEIJING, Oct. 11, 2024 /PRNewswire/ -- China Liberal Education Holdings Limited (Nasdaq: CLEU) ("China Liberal," the "Company," "we," "our," or "us"), aChina -based company that provides technological consulting services for smart campus solutions and other educational services, today announced it...

2024-10-12 04:05 5589

WiMi Announced a Federated Learning Framework Based on Layered and Sharded Blockchain Technology

BEIJING, Oct. 11, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced a federated learning framework based on layered and sharded blockchain technology, which can solve mult...

2024-10-11 23:40 3322

CNEY Regains Compliance with Nasdaq Minimum Market Value of Publicly Held Shares Requirement

LISHUI, China, Oct. 11, 2024 /PRNewswire/ -- CN Energy Group. Inc. (the "Company"; NASDAQ: CNEY), today announced that onOctober 9, 2024, Company received a written notice from Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained ...

2024-10-11 21:00 2969

CLPS Incorporation to Announce Second Half and Full Year of Fiscal 2024 Financial Results

HONG KONG, Oct. 11, 2024 /PRNewswire/ -- CLPS Incorporation (Nasdaq: CLPS) ("CLPS" or the "Company"), today announced that it will release its second half and full year of fiscal 2024 financial results before the market opens on Friday, October 18, 2024. About CLPS Incorporation Headquartered in...

2024-10-11 20:30 4704

Baird Medical Announces Preliminary Financial Results for the Six Months Ended June 30, 2024

Total revenues increased to US$13.1 million, representing 13.8% year-over-year growth Net income reached US$4.4 million, representing 85.8% year-over-year growth GUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"...

2024-10-11 20:00 4386
1 ... 18192021222324 ... 772